Clinical Trials Sponsored by ICON plc

Total 11515 results

Shanghai Proton and Heavy Ion Center

Completed

Proton and Carbon Ion Radiotherapy for Locally Advanced Pancreatic Cancer

Pancreatic Carcinoma

China
Shanghai Proton and Heavy Ion Center

Terminated

Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center

Unknown

Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma

Adenoid Cystic Carcinoma

China
Children's Hospital of Philadelphia
Lucky Iron Fish

Completed

Iron Fish in Dominican Republic (DR) Children

Iron-deficiency | Anemia | Iron Deficiency Anemia

Dominican Republic
Herantis Pharma Plc.
Renishaw plc.

Completed

Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study

Brain Diseases | Nervous System Diseases | Parkinson Disease | Movement Disorders | Neuro-Degenerative Disease

Sweden, Finland
Herantis Pharma Plc.
Renishaw plc.

Completed

Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease

Brain Diseases | Nervous System Diseases | Parkinson Disease | Movement Disorders | Neurodegenerative Diseases

Sweden, Finland
University of Roma La Sapienza
ICOT University Hospital

Recruiting

Antibodies Response to mRNA Vaccine Against Covid-19 (SCAREAID)

Covid-19

Italy
ICAN Nutrition Education and Research
California Walnut Commission

Completed

Effects of Daily Walnut Intake Among the Subjects With Metabolic Syndrome

Metabolic Syndrome

Korea, Republic of
Reckitt Benckiser LLC
Premier Research Group plc; Aptuit Inc.

Completed

Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study

Post-operative Pain

United States
Corium, Inc.
Premier Research Group plc; Almac; Prometrika, LLC

Active, not recruiting

An Efficacy and Safety Study w/ Azstarys® in Children With ADHD (KP415P01)

Attention Deficit/Hyperactivity Disorder

United States
Optos, PLC

Recruiting

P200TE and Predicate Agreement and Precision Study

Glaucoma | Normal | Retina Disease

United States
NuCana plc

Recruiting

A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

Lymphoma | Solid Tumor | Advanced Cancer

United Kingdom
Optos, PLC

Active, not recruiting

P200TE US Reference Database Study

Normal Eyes

United States
Optos, PLC

Terminated

Data Collection With the P200TE and P200TxE

Retinal Disease

United States
Optos, PLC

Completed

Optic Disc Photograph Collection Study

Glaucoma | Normal | Retina Disease

United States
NuCana plc

Terminated

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Biliary Tract Cancer

Canada, United States, Spain, Hungary, Korea, Republic of, United Kingdom, Czechia, Germany, Russian Federation, Australia, France, Taiwan, Ukraine, Italy, Turkey
Optos, PLC

Completed

Study Comparing the P200TE and the P200TxE in Glaucoma Patients

Glaucoma

United States
NuCana plc

Active, not recruiting

A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer

Colorectal Neoplasms | Colorectal Cancer | Colorectal Cancer Metastatic | Colorectal Adenocarcinoma | Neoplasm, Colorectal

United States, Spain, United Kingdom, Italy, Germany, France
Angle plc

Completed

Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System (HOMING)

Healthy Volunteers | Breast Cancer, Metastatic

United States
Optos, PLC

Terminated

P200TE Agreement and Precision Study

Glaucoma | Normal | Retina Disease

United States
Pharmexa A/S
Syneos Health; ICON Clinical Research; ORION Clinical Services; CIRION Central... and other collaborators

Terminated

GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer

Advanced Unresectable Pancreatic Cancer

United States, Spain, Australia, Netherlands, Belgium, Denmark, France, Ireland, Italy, Norway, Poland, Sweden
Optos, PLC

Recruiting

Glaucoma Evaluation With the P200TE

Glaucoma

United States
Optos, PLC

Recruiting

P200TxE Diseased Eye Image Collection

Retinal Disease

United States
NuCana plc

Recruiting

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Melanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Advanced Cancer | Head and Neck Squamous Cell Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Classical Hodgkin Lymphoma | Neoplasm Malignant | Pleural... and other conditions

United Kingdom
NuCana plc

Completed

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

Colorectal Neoplasms | Colorectal Cancer | Colorectal Tumors | Colorectal Carcinoma | Neoplasms, Colorectal

United States, France, United Kingdom
ValiRx Plc

Completed

Dose Finding Safety Study of VAL201 in Cancer Patients (VAL201-001)

Stage III Prostate Carcinoma | Stage IV Prostate Carcinoma
Optos, PLC

Completed

Navigated OCT Imaging With the P200TxE

Retinal Disease

United States
NuCana plc

Terminated

NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer

Ovarian Cancer

United States, United Kingdom
Optos, PLC

Completed

Image Collection of Normal Eyes for Development of an EU RDB

Healthy

United Kingdom
Optos, PLC

Completed

Optos P200TE Agreement and Precision Study

Glaucoma | Retinal Disease

United States
Viatar LLC
Commonwealth Hematology-Oncology, P.C.

Completed

Collection of Blood Specimens for Circulating Tumor Cell Analysis

Breast Cancer | Colorectal Cancer | Prostate Cancer

United States
Shanghai Proton and Heavy Ion Center

Recruiting

Carbon Ion Radiotherapy for Recurrent Pancreatic Cancer Post Surgery

Pancreatic Carcinoma

China
Shanghai Proton and Heavy Ion Center

Recruiting

A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

Triple Negative Breast Cancer | HER2-positive Breast Cancer

China
Shanghai Proton and Heavy Ion Center

Recruiting

Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Shanghai Proton and Heavy Ion Center

Recruiting

Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer

Pancreatic Cancer Non-resectable

China
Shanghai Proton and Heavy Ion Center

Recruiting

Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

Localized Prostate Cancer

China
Shanghai Proton and Heavy Ion Center

Recruiting

12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer

Prostate Cancer | Radiotherapy

China
Shanghai Proton and Heavy Ion Center

Recruiting

Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer

Prostate Carcinoma

China
Shanghai Proton and Heavy Ion Center

Terminated

Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Shanghai Proton and Heavy Ion Center

Completed

Proton and Carbon Ion Radiotherapy for Cervical Cancer

Cervical Cancer
Shanghai Proton and Heavy Ion Center

Unknown

Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer

Metastatic Prostate Carcinoma

China
Derm Research, PLLC
WFH MEDICAL, LLC

Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Acne Vulgaris

United States
Universal Diagnostics
Premier Research Group plc; Science 37; Yanuvia, LLC

Recruiting

A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation

Colorectal Cancer | Advanced Adenocarcinoma

United States
Acacia Pharma Ltd
Premier Research Group plc; Amicus CD LLC

Recruiting

Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients

Nausea and Vomiting, Postoperative

Canada, United States, Germany, France
Nova Therapeutics LLC
Chinese PLA General Hospital

Recruiting

CART-PSMA Cells for Advanced Prostate Cancer

Prostate Cancer

China
ICAN Nutrition Education and Research
Almond Board of California

Completed

Effects of Daily Almond Intake as a Preload Before Meals Versus as a Snack Among Korean Adults

Adult Young and Healthy

Korea, Republic of
Jian Chen

Recruiting

Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor

Thymic Epithelial Tumor | Radiotherapy Side Effect | Carbon Ion Radiotheray | Heavy Ion Radiotherapy

China
Jian Chen

Recruiting

Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors

Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy

China
Xin Cai

Not yet recruiting

Re-irradiation Therapy of Locally Recurrent Rectal Cancer With Carbon Ion

Rectal Cancer | Recurrent

China
ICN Pharmaceuticals

Terminated

The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection

HIV Infections

Clinical Trials Sponsored by ICON plc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations